Rhythm Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.

CEO

David P. Meeker

CEODavid P. Meeker

Employees

226

Employees226

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2008

Founded2008

Employees

226

Employees226

RYTM Key Statistics

Market cap

2.64B

Market cap2.64B

Price-Earnings ratio

-13.64

Price-Earnings ratio-13.64

Dividend yield

—

Dividend yield—

Average volume

522.00K

Average volume522.00K

High today

$44.37

High today$44.37

Low today

$42.71

Low today$42.71

Open price

$43.58

Open price$43.58

Volume

981.99K

Volume981.99K

52 Week high

$52.57

52 Week high$52.57

52 Week low

$15.50

52 Week low$15.50

RYTM News

Simply Wall St 1d

Rhythm Pharmaceuticals, Inc.'s Shares May Have Run Too Fast Too Soon - Simply Wall St

Rhythm Pharmaceuticals, Inc.'s ( ) price-to-sales (or "P/S") ratio of 34.5x might make it look like a strong sell right now compared to the Biotechs industry in...

Yahoo Finance 6d

Earnings Preview: Rhythm Pharmaceuticals, Inc. Q1 Earnings Expected to Decline - Yahoo Finance

The market expects Rhythm Pharmaceuticals, Inc. (RYTM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarte...

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell